Quercis Pharma

Central African Republic
Bayanga, Sangha-Mbaéré, Central African Republic

Company profile

Quercis Pharma company profile

Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases. It is advancing a development pipeline of late-stage clinical studies that focus on the prevention of VTE in cancer patients. In addition, Quercis targets other diseases associated with thrombotic events, such as sickle cell disease (SCD), Ebola, and COVID-19. The Company’s lead drug candidate acts as an antithrombotic with a significantly lower risk of adverse events than existing treatments. The company was founded in 2019 and is based in Zug, Switzerland.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2019-01-01, Year

Headquarters

Country code
CF
Continent
Africa

Capital profile

Funding and company signals

Funding stage
Private Equity
Funding rounds
1
Total equity funding
$150M
Last funding
Private Equity / $150M / 2021-12-09
Last equity funding
Private Equity / $150M
Investors
1
Lead investors
1
Articles
20

Founders and investors

Lead investors

The Global Emerging Markets Group

Investors

The Global Emerging Markets Group